应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
AORT Artivion
盘后交易 05-08 19:14:25 EDT
28.53
+0.15
+0.53%
盘后
28.53
+0.00
0.00%
16:05 EDT
最高
29.13
最低
28.07
成交量
62.54万
今开
28.52
昨收
28.38
日振幅
3.72%
总市值
12.18亿
流通市值
10.62亿
总股本
4,270万
成交额
1,799万
换手率
1.68%
流通股本
3,723万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Artivion, Inc.2024财年实现净利润-13.36百万美元,同比增加56.30%
市场透视 · 02-28
Artivion, Inc.2024财年实现净利润-13.36百万美元,同比增加56.30%
Citizens Capital Markets:重申Artivion(AORT.US)评级,由优于大市调整至优于大市评级, 目标价由33.00美元调整至33.00美元。
金融界 · 02-25
Citizens Capital Markets:重申Artivion(AORT.US)评级,由优于大市调整至优于大市评级, 目标价由33.00美元调整至33.00美元。
Artivion, Inc.盘中异动 早盘急速跳水7.36%报25.80美元
市场透视 · 02-25
Artivion, Inc.盘中异动 早盘急速跳水7.36%报25.80美元
异动解读 | Artivion营收不及预期 盘后大跌6.64%
异动解读 · 02-24
异动解读 | Artivion营收不及预期 盘后大跌6.64%
Artivion第四季度调整后每股收益为$0,低于预期的$-0.06;销售额为$97.31M,低于预期的$100.82M
财报速递 · 02-24
Artivion第四季度调整后每股收益为$0,低于预期的$-0.06;销售额为$97.31M,低于预期的$100.82M
Needham:重申Artivion(AORT.US)评级,由买入调整至买入评级, 目标价由34.00美元调整至34.00美元。
金融界 · 01-28
Needham:重申Artivion(AORT.US)评级,由买入调整至买入评级, 目标价由34.00美元调整至34.00美元。
Artivion, Inc.盘中异动 股价大涨5.30%报31.65美元
市场透视 · 01-16
Artivion, Inc.盘中异动 股价大涨5.30%报31.65美元
Artivion, Inc.2024财年第三财季实现净利润-2.29百万美元,同比增加76.54%
市场透视 · 2024-11-16
Artivion, Inc.2024财年第三财季实现净利润-2.29百万美元,同比增加76.54%
Artivion, Inc.盘中异动 快速下跌5.66%
市场透视 · 2024-11-08
Artivion, Inc.盘中异动 快速下跌5.66%
Artivion, Inc.盘中异动 早盘大幅拉升5.74%报29.49美元
市场透视 · 2024-11-06
Artivion, Inc.盘中异动 早盘大幅拉升5.74%报29.49美元
加载更多
公司概况
公司名称:
Artivion
所属市场:
NYSE
上市日期:
--
主营业务:
Artivion, Inc.于 1984 年在佛罗里达州注册成立,并于2022年1月1日将其注册地址从佛罗里达州更改为特拉华州,是生产,加工和分销医疗器械和植入式人体组织的领先企业,专注于主动脉修复。 他们的医疗设备和加工组织主要包括四个产品系列:BioGlue外科胶粘剂(“BioGlue”); On-X机械心脏瓣膜和手术产品; JOTEC血管内和外科产品; 以及包括CryoValve SG肺心脏瓣膜(“CryoValve SGPV”)和CryoPatch SG肺心脏贴片(“CryoPatch SG”)在内的心脏和血管人体组织,两者均使用其专有的SynerGraft技术加工。 其他产品包括CardioGenesis心脏激光疗法,PerClot和PhotoFixTM。
发行价格:
--
{"stockData":{"symbol":"AORT","market":"US","secType":"STK","nameCN":"Artivion","latestPrice":28.53,"timestamp":1746734400000,"preClose":28.38,"halted":0,"volume":625359,"hourTrading":{"tag":"盘后","latestPrice":28.53,"preClose":28.53,"latestTime":"16:05 EDT","volume":3599,"amount":102679.47,"timestamp":1746734712171},"delay":0,"floatShares":37232515,"shares":42702785,"eps":-0.533937,"marketStatus":"盘后交易","change":0.15,"latestTime":"05-08 19:14:25 EDT","open":28.52,"high":29.125,"low":28.07,"amount":17986865.099217,"amplitude":0.037174,"askPrice":32.56,"askSize":100,"bidPrice":25.61,"bidSize":80,"shortable":3,"etf":0,"ttmEps":-0.533937,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1746748800000},"marketStatusCode":4,"adr":0,"listingDate":868939200000,"exchange":"NYSE","adjPreClose":28.38,"preHourTrading":{"tag":"盘前","latestPrice":28.52,"preClose":28.38,"latestTime":"08:00 EDT","volume":268,"amount":7649.749656,"timestamp":1746705622638},"postHourTrading":{"tag":"盘后","latestPrice":28.53,"preClose":28.53,"latestTime":"16:05 EDT","volume":3599,"amount":102679.47,"timestamp":1746734712171},"volumeRatio":0.615633,"impliedVol":0.5531,"impliedVolPercentile":0.864},"requestUrl":"/m/hq/s/AORT","defaultTab":"news","newsList":[{"id":"2516376743","title":"Artivion, Inc.2024财年实现净利润-13.36百万美元,同比增加56.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516376743","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516376743?lang=zh_cn&edition=full","pubTime":"2025-03-01 00:00","pubTimestamp":1740758444,"startTime":"0","endTime":"0","summary":"3月1日,Artivion, Inc.公布财报,公告显示公司2024财年净利润为-13.36百万美元,同比增加56.30%;其中营业收入为3.89亿美元,同比增加9.89%,每股基本收益为-0.32美元。从资产负债表来看,Artivion, Inc.总负债5.13亿美元,其中短期债务5.29百万美元,资产负债比为1.54,流动比率为0.04。机构评级:截至2025年3月1日,当前有6家机构对Artivion, Inc.目标价做出预测,其中目标均价为32.33美元,其中最低目标价为30.00美元,最高目标价为35.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301000054abe0ffa4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301000054abe0ffa4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AORT"],"gpt_icon":0},{"id":"2514016991","title":"Citizens Capital Markets:重申Artivion(AORT.US)评级,由优于大市调整至优于大市评级, 目标价由33.00美元调整至33.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514016991","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514016991?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:41","pubTimestamp":1740498087,"startTime":"0","endTime":"0","summary":"Citizens Capital Markets:重申Artivion(AORT.US)评级,由优于大市调整至优于大市评级, 目标价由33.00美元调整至33.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/25234148384497.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["AORT"],"gpt_icon":0},{"id":"2514090314","title":"Artivion, Inc.盘中异动 早盘急速跳水7.36%报25.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514090314","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514090314?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:36","pubTimestamp":1740494161,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时36分,Artivion, Inc.股票出现异动,股价快速下挫7.36%。截至发稿,该股报25.80美元/股,成交量3747股,换手率0.01%,振幅0.07%。Artivion, Inc.股票所在的医疗器械行业中,整体跌幅为0.01%。Artivion, Inc.公司简介:Artivion Inc 为心脏和血管外科医生提供一套主动脉为中心的解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223601abdc7f52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223601abdc7f52&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE0031619046.USD","IE00B19Z4B17.USD","IE00B66KJ199.SGD","IE00B7SZL793.SGD","AORT","BK4082"],"gpt_icon":0},{"id":"1102635029","title":"异动解读 | Artivion营收不及预期 盘后大跌6.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=1102635029","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102635029?lang=zh_cn&edition=full","pubTime":"2025-02-25 06:02","pubTimestamp":1740434560,"startTime":"0","endTime":"0","summary":"医疗器械公司Artivion(AORT)周一盘后交易中大跌6.64%,因公司最新公布的第四季度业绩未达分析师预期。\n数据显示,Artivion第四季度销售额为9731万美元,较去年同期增长3.88%,但低于分析师预期的1.0082亿美元。季绩不佳导致资金撤离,引发Artivion盘后股价暴跌。\n分析人士指出,医疗器械行业竞争激烈,如果Artivion未来无法实现预期销售增长,将对公司业绩和股价造成进一步压力。市场将持续关注Artivion后续财报,评估其业务发展势头。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["AORT"],"gpt_icon":0},{"id":"1118685764","title":"Artivion第四季度调整后每股收益为$0,低于预期的$-0.06;销售额为$97.31M,低于预期的$100.82M","url":"https://stock-news.laohu8.com/highlight/detail?id=1118685764","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1118685764?lang=zh_cn&edition=full","pubTime":"2025-02-25 05:21","pubTimestamp":1740432065,"startTime":"0","endTime":"0","summary":"Artivion 报告季度销售额为$97.31百万,比分析师的预期$100.82百万低3.48%。这比去年同期$93.67百万的销售额增长了3.88%。以上内容来自Benzinga Earnings专栏,原文如下:$Artivion$ reported quarterly sales of $97.31 million which missed the analyst consensus estimate of $100.82 million by 3.48 percent. This is a 3.88 percent increase over sales of $93.67 million the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Artivion第四季度调整后每股收益为$0,低于预期的$-0.06;销售额为$97.31M,低于预期的$100.82M","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AORT"],"gpt_icon":0},{"id":"2507458175","title":"Needham:重申Artivion(AORT.US)评级,由买入调整至买入评级, 目标价由34.00美元调整至34.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2507458175","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507458175?lang=zh_cn&edition=full","pubTime":"2025-01-29 00:30","pubTimestamp":1738081842,"startTime":"0","endTime":"0","summary":"Needham:重申Artivion(AORT.US)评级,由买入调整至买入评级, 目标价由34.00美元调整至34.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/29003047883380.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["AORT"],"gpt_icon":0},{"id":"2503191879","title":"Artivion, Inc.盘中异动 股价大涨5.30%报31.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503191879","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503191879?lang=zh_cn&edition=full","pubTime":"2025-01-16 22:37","pubTimestamp":1737038253,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日22时37分,Artivion, Inc.股票出现波动,股价快速拉升5.30%。截至发稿,该股报31.65美元/股,成交量4.3507万股,换手率0.10%,振幅1.76%。Artivion, Inc.股票所在的医疗器械行业中,整体涨幅为0.76%。Artivion, Inc.公司简介:Artivion Inc 为心脏和血管外科医生提供一套主动脉为中心的解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116223733abad50f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116223733abad50f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AORT","IE00B66KJ199.SGD","IE0031619046.USD","IE00B19Z4B17.USD","IE00B7SZL793.SGD","BK4082"],"gpt_icon":0},{"id":"2484954369","title":"Artivion, Inc.2024财年第三财季实现净利润-2.29百万美元,同比增加76.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484954369","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484954369?lang=zh_cn&edition=full","pubTime":"2024-11-17 00:02","pubTimestamp":1731772953,"startTime":"0","endTime":"0","summary":"11月17日,Artivion, Inc.公布财报,公告显示公司2024财年第三财季净利润为-2.29百万美元,同比增加76.54%;其中营业收入为95.78百万美元,同比增加9.03%,每股基本收益为-0.05美元。从资产负债表来看,Artivion, Inc.总负债4.98亿美元,其中短期债务1.05亿美元,资产负债比为1.62,流动比率为1.56。机构评级:截至2024年11月17日,当前有6家机构对Artivion, Inc.目标价做出预测,其中目标均价为33.17美元,其中最低目标价为32.00美元,最高目标价为35.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000322a23e064e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000322a23e064e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AORT"],"gpt_icon":0},{"id":"2481310298","title":"Artivion, Inc.盘中异动 快速下跌5.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481310298","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481310298?lang=zh_cn&edition=full","pubTime":"2024-11-08 22:45","pubTimestamp":1731077149,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日22时45分,Artivion, Inc.股票出现异动,股价急速下挫5.66%。Artivion, Inc.股票所在的医疗器械行业中,整体涨幅为0.55%。其相关个股中,Tivic Health Systems, Inc.、Nexalin Technology Inc C/Wts 、Lensar, Inc.涨幅较大,Tivic Health Systems, Inc.、Bluejay Diagnostics, Inc.、Ainos, Inc.较为活跃,换手率分别为2786.95%、13.00%、9.91%,振幅较大的相关个股有Tivic Health Systems, Inc.、Clearpoint Neuro Inc.、Pacific Biosciences Of California, Inc.,振幅分别为84.61%、20.86%、19.18%。Artivion, Inc.公司简介:Artivion Inc 为心脏和血管外科医生提供一套主动脉为中心的解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108224549971a5623&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108224549971a5623&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AORT","IE00B7SZL793.SGD","IE00B19Z4B17.USD","IE00B66KJ199.SGD","IE0031619046.USD","BK4082"],"gpt_icon":0},{"id":"2481983610","title":"Artivion, Inc.盘中异动 早盘大幅拉升5.74%报29.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481983610","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481983610?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:31","pubTimestamp":1730903505,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时31分,Artivion, Inc.股票出现异动,股价急速上涨5.74%。截至发稿,该股报29.49美元/股,成交量1.7448万股,换手率0.04%,振幅3.08%。Artivion, Inc.股票所在的医疗器械行业中,整体涨幅为1.59%。Artivion, Inc.公司简介:Artivion Inc 为心脏和血管外科医生提供一套主动脉为中心的解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223145971a4bb8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223145971a4bb8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B66KJ199.SGD","IE0031619046.USD","AORT","IE00B19Z4B17.USD","BK4082","IE00B7SZL793.SGD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.artivion.com","stockEarnings":[{"period":"1week","weight":0.198},{"period":"1month","weight":0.2291},{"period":"3month","weight":-0.0924},{"period":"6month","weight":-0.0115},{"period":"1year","weight":0.1939},{"period":"ytd","weight":-0.0073}],"compareEarnings":[{"period":"1week","weight":0.0119},{"period":"1month","weight":0.1126},{"period":"3month","weight":-0.0745},{"period":"6month","weight":-0.0619},{"period":"1year","weight":0.0851},{"period":"ytd","weight":-0.0425}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Artivion, Inc.于 1984 年在佛罗里达州注册成立,并于2022年1月1日将其注册地址从佛罗里达州更改为特拉华州,是生产,加工和分销医疗器械和植入式人体组织的领先企业,专注于主动脉修复。 他们的医疗设备和加工组织主要包括四个产品系列:BioGlue外科胶粘剂(“BioGlue”); On-X机械心脏瓣膜和手术产品; JOTEC血管内和外科产品; 以及包括CryoValve SG肺心脏瓣膜(“CryoValve SGPV”)和CryoPatch SG肺心脏贴片(“CryoPatch SG”)在内的心脏和血管人体组织,两者均使用其专有的SynerGraft技术加工。 其他产品包括CardioGenesis心脏激光疗法,PerClot和PhotoFixTM。","yearOnYearQuotes":[{"month":1,"riseRate":0.4375,"avgChangeRate":0.010603},{"month":2,"riseRate":0.5,"avgChangeRate":0.006023},{"month":3,"riseRate":0.393939,"avgChangeRate":-0.010393},{"month":4,"riseRate":0.606061,"avgChangeRate":0.06644},{"month":5,"riseRate":0.515152,"avgChangeRate":0.063055},{"month":6,"riseRate":0.65625,"avgChangeRate":0.032754},{"month":7,"riseRate":0.53125,"avgChangeRate":-0.003339},{"month":8,"riseRate":0.46875,"avgChangeRate":0.009905},{"month":9,"riseRate":0.65625,"avgChangeRate":0.035491},{"month":10,"riseRate":0.375,"avgChangeRate":-0.033391},{"month":11,"riseRate":0.53125,"avgChangeRate":0.016814},{"month":12,"riseRate":0.53125,"avgChangeRate":0.023511}],"exchange":"NYSE","name":"Artivion","nameEN":"Artivion"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.4","shortVersion":"4.33.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Artivion(AORT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Artivion(AORT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Artivion,AORT,Artivion股票,Artivion股票老虎,Artivion股票老虎国际,Artivion行情,Artivion股票行情,Artivion股价,Artivion股市,Artivion股票价格,Artivion股票交易,Artivion股票购买,Artivion股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Artivion(AORT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Artivion(AORT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}